** = Publikationen gelistet in SCI/SSCI/Pubmed
** Berg, JL; Perfler, B; Hatzl, S; Mayer, MC; Wurm, S; Uhl, B; Reinisch, A; Klymiuk, I; Tierling, S; Pregartner, G; Bachmaier, G; Berghold, A; Geissler, K; Pichler, M; Hoefler, G; Strobl, H; Wölfler, A; Sill, H; Zebisch, A
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Clin Epigenetics. 2021; 13(1): 1-1.
Doi: 10.1186/s13148-020-00979-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Berg, JL; Perfler, B; Hatzl, S; Uhl, B; Reinisch, A; Pregartner, G; Berghold, A; Penz, T; Schuster, M; Geissler, K; Prokesch, A; Müller-Tidow, C; Hoefler, G; Kashofer, K; Wölfler, A; Sill, H; Caraffini, V; Zebisch, A
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
Leukemia. 2021; 35(5):1521-1526
Doi: 10.1038/s41375-021-01161-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mayer, MC; Berg, JL; Perfler, B; Hatzl, S; Herzog, SA; Bachmaier, G; Berghold, A; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A
miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.
ANN HEMATOL. 2021; 100(11): 2845-2847.
Doi: 10.1007/s00277-021-04598-6
Web of Science
PubMed
FullText
FullText_MUG
** Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Schauer, S; Beham-Schmid, C; Hoefler, G; Geissler, K; Quehenberger, F; Kolch, W; Athineos, D; Blyth, K; Wölfler, A; Sill, H; Zebisch, A
Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.
Haematologica. 2020; 105(2):375-386
Doi: 10.3324/haematol.2018.209650
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Perfler, B; Wurm, S; Uhl, B; Quehenberger, F; Ebner, S; Troppmair, J; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A
Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia.
Cancers (Basel). 2020; 12(2):
Doi: 10.3390/cancers12020496
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Caraffini, V; Perfler, B; Berg, JL; Uhl, B; Schauer, S; Kashofer, K; Ghaffari-Tabrizi-Wizsy, N; Strobl, H; Wölfler, A; Hoefler, G; Sill, H; Zebisch, A
Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.
Blood. 2018; 131(7): 826-830.
Doi: 10.1182/blood-2017-09-804906
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG